Study of spliceosome-targeting cancer therapies reveals an overlooked role of mis-spliced RNAs themselves
Endogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Read moreEndogenous mis-spliced RNA in tumor cells mimics an RNA virus, leading tumor cells to self-destruct as if fighting an infection.
Read moreAn ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read moreClinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read moreWhen Samir Tanios was diagnosed with malignant pleural mesothelioma in September 2018, he was in poor condition. He couldn’t take a deep breath or walk
Read moreBy 2030, the number of new cancer cases per year is expected to increase by 23.6 million worldwide. While radiation and chemotherapy continue to be
Read morePancreatic cancer is one of the most challenging types of cancer to treat, but new therapy using the body’s own immune system is providing new
Read moreMelanoma is the deadliest form of skin cancer in the world. While traditional therapies include chemotherapy, radiation, and surgery, immunotherapy has emerged as an effective
Read moreNeuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read moreSince he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read moreA few years ago, Katherine Dill was leading a full life with her two children in Texas when she noticed something different about her face.
Read more